“…Before commencing therapy, it is highly recommended to consider any concomitant medications and the patient's preference, especially when treating persons who have diabetes mellitus, liver disease or are immunocompromised (7,105). Although ketoconazole and fluconazole are often prescribed for the treatment of onychomycosis, only griseofulvin, itraconazole and terbinafine are approved by the US Food and Drug Administration (FDA) and currently licensed for the treatment of this condition in the United States and United Kingdom (1,4,7,44,51,82,99,100,(104)(105)(106).…”